Target intelligence / Profile preview

Macromolecular synthesis and metabolic pathways

Molecular classification
Other
01

Overview

Macromolecular synthesis and metabolic pathways encompass the complex network of chemical reactions that allow cells to produce essential biological polymers—DNA, RNA, and proteins—and generate energy (NIH, 2023). These processes are fundamental to cellular homeostasis, growth, and division, involving both catabolic pathways that break down nutrients and anabolic pathways that build cellular components (StatPearls, 2023). In pathological states like cancer, these pathways are often reprogrammed to support uncontrolled proliferation, a phenomenon known as metabolic reprogramming (Nature Reviews Cancer, 2011). Many classic chemotherapeutic agents, such as antimetabolites, target specific enzymes within these pathways to inhibit DNA synthesis or protein production (PubMed, 2022). Because these pathways are also vital for healthy cells, drugs targeting them frequently cause systemic toxicities, such as bone marrow suppression and mucosal damage (NIH, 2023). This entry is considered incorrect as a single therapeutic target because it describes a broad set of biological processes rather than a specific molecular entity.

Other names
Cellular metabolismBiomacromolecule biosynthesisMetabolic networksAnabolism and catabolism
02

Mechanism of action

Drugs targeting these pathways typically act as antimetabolites that mimic natural substrates to inhibit rate-limiting enzymes or as inhibitors of the machinery responsible for polymerizing nucleic acids and proteins.

03

Biological functions

Cell proliferationEnergy metabolismProtein synthesisDNA replicationRNA transcriptionLipid biosynthesis
04

Disease associations

CancerInfectionMetabolic diseaseInflammationGenetic metabolic disorders
05

Safety considerations

MyelosuppressionGastrointestinal toxicityHepatotoxicityNarrow therapeutic indexSystemic cytotoxicity in healthy rapidly dividing cells
06

Interacting drugs

Methotrexate

6 more in the full profile.

07

Biomarkers

Ki-67 proliferation indexLactate dehydrogenase (LDH) levelsFluorodeoxyglucose (FDG) uptakeCirculating metabolite profiles

Beyond the preview

Go deeper on Macromolecular synthesis and metabolic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macromolecular synthesis and metabolic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call